Phase I/II Study of Sagopilone in combination with carboplatin and bevacizumab in the first-line treatment of patients with stage IIIB/IV, non-squamous NSCLC.
Phase of Trial: Phase I/II
Latest Information Update: 24 May 2012
At a glance
- Drugs Bevacizumab; Carboplatin; Sagopilone
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 29 Jul 2011 New trial record